| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.442 | 0.005 | 0.442 | Cell adhesion inhibitor | 0.388 0.005 CID_154699600 0.402 0.005 CID_13471531 | ||
| 0.445 | 0.016 | 0.445 | Psychostimulant | 0.38 0.026 CID_154699600 0.408 0.021 CID_13471531 | ||
| 0.384 | 0.005 | 0.384 | Gastrin inhibitor | 0.314 0.024 CID_154699600 0.324 0.019 CID_13471531 | ||
| 0.416 | 0.068 | 0.427 | 5 Hydroxytryptamine release inhibitor | 0.361 0.106 CID_154699600 0.427 0.062 CID_13471531 | CID_13471531 | |
| 0.397 | 0.05 | 0.404 | Antithrombotic | 0.321 0.076 CID_154699600 0.404 0.048 CID_13471531 | CID_13471531 | |
| 0.37 | 0.028 | 0.37 | Insulysin inhibitor | 0.332 0.041 CID_154699600 0.37 0.028 CID_13471531 | ||
| 0.336 | 0.005 | 0.336 | Integrin antagonist | 0.232 0.006 CID_154699600 0.244 0.005 CID_13471531 | ||
| 0.389 | 0.065 | 0.604 | Toll-Like receptor agonist | 0.604 0.017 CID_154699600 0.368 0.074 CID_13471531 | CID_154699600 | |
| 0.374 | 0.051 | 0.401 | 5 Hydroxytryptamine release stimulant | 0.208 0.115 CID_154699600 0.401 0.046 CID_13471531 | CID_13471531 | |
| 0.341 | 0.018 | 0.376 | Tyrosine 3 hydroxylase inhibitor | 0.316 0.026 CID_154699600 0.376 0.011 CID_13471531 | CID_13471531 | |
| 0.325 | 0.007 | 0.377 | Nitric-oxide synthase stimulant | 0.299 0.012 CID_154699600 0.377 0.004 CID_13471531 | CID_13471531 | |
| 0.382 | 0.067 | 0.603 | Toll-Like receptor 7 agonist | 0.603 0.017 CID_154699600 0.363 0.076 CID_13471531 | CID_154699600 | |
| 0.294 | 0.005 | 0.294 | Cell adhesion molecule inhibitor | 0.214 0.009 CID_154699600 0.234 0.007 CID_13471531 | ||
| 0.3 | 0.03 | 0.3 | Calpain inhibitor | 0.264 0.053 CID_154699600 0.285 0.038 CID_13471531 | ||
| 0.325 | 0.058 | 0.33 | Interleukin 2 agonist | 0.32 0.061 CID_154699600 0.33 0.055 CID_13471531 | CID_13471531 | |
| 0.264 | 0.004 | 0.264 | Phosphorylase inhibitor | 0.164 0.006 CID_154699600 0.239 0.004 CID_13471531 | ||
| 0.263 | 0.004 | 0.263 | Integrin alpha4 antagonist | 0.193 0.004 CID_154699600 0.198 0.004 CID_13471531 | ||
| 0.272 | 0.018 | 0.3 | Neurotensin receptor agonist | 0.255 0.02 CID_154699600 0.3 0.014 CID_13471531 | CID_13471531 | |
| 0.297 | 0.046 | 0.305 | 5 Hydroxytryptamine uptake stimulant | 0.305 0.042 CID_154699600 0.292 0.049 CID_13471531 | CID_154699600 | |
| 0.301 | 0.052 | 0.301 | Platelet antagonist | 0.273 0.063 CID_154699600 0.273 0.063 CID_13471531 | ||
| 0.338 | 0.093 | 0.338 | Calpain 2 inhibitor | 0.232 0.162 CID_154699600 0.276 0.131 CID_13471531 | ||
| 0.272 | 0.029 | 0.272 | Thrombolytic | 0.239 0.036 CID_154699600 0.268 0.03 CID_13471531 | ||
| 0.245 | 0.029 | 0.245 | 3C-like protease (Human coronavirus) inhibitor | 0.156 0.091 CID_154699600 0.206 0.048 CID_13471531 | ||
| 0.317 | 0.105 | 0.317 | GABA C receptor rho-3 antagonist | 0.234 0.169 CID_154699600 0.312 0.108 CID_13471531 | ||
| 0.214 | 0.014 | 0.214 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.155 0.025 CID_154699600 0.144 0.028 CID_13471531 | ||
| 0.349 | 0.152 | 0.349 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.249 | 0.057 | 0.249 | Neuropeptide Y2 antagonist | 0.203 0.114 CID_154699600 0.24 0.066 CID_13471531 | ||
| 0.262 | 0.071 | 0.262 | Interleukin agonist | 0.222 0.101 CID_154699600 0.235 0.09 CID_13471531 | ||
| 0.189 | 0.005 | 0.189 | NMDA receptor agonist | 0.118 0.014 CID_154699600 0.137 0.01 CID_13471531 | ||
| 0.227 | 0.044 | 0.227 | Anticoagulant | 0.163 0.07 CID_154699600 0.195 0.055 CID_13471531 | ||
| 0.219 | 0.038 | 0.219 | Diuretic | 0.178 0.055 CID_154699600 0.189 0.049 CID_13471531 | ||
| 0.229 | 0.048 | 0.237 | Insulin sensitizer | 0.215 0.059 CID_154699600 0.237 0.042 CID_13471531 | CID_13471531 | |
| 0.207 | 0.027 | 0.212 | Catenin beta inhibitor | 0.185 0.046 CID_154699600 0.212 0.024 CID_13471531 | CID_13471531 | |
| 0.186 | 0.017 | 0.186 | Cathepsin G inhibitor | 0.14 0.023 CID_154699600 0.158 0.02 CID_13471531 | ||
| 0.181 | 0.013 | 0.181 | Folate antagonist | 0.157 0.02 CID_154699600 0.167 0.017 CID_13471531 | ||
| 0.272 | 0.107 | 0.294 | Apoptosis antagonist | 0.276 0.103 CID_154699600 0.294 0.09 CID_13471531 | CID_13471531 | |
| 0.169 | 0.004 | 0.169 | VLA-4 antagonist | 0.143 0.004 CID_154699600 0.144 0.004 CID_13471531 | ||
| 0.18 | 0.017 | 0.238 | NMDA receptor antagonist | 0.163 0.021 CID_154699600 0.238 0.01 CID_13471531 | CID_13471531 | |
| 0.163 | 0.003 | 0.163 | Integrin alpha4beta7 antagonist | 0.121 0.003 CID_154699600 0.12 0.003 CID_13471531 | ||
| 0.268 | 0.115 | 0.319 | Vasodilator, peripheral | 0.319 0.087 CID_154699600 0.258 0.122 CID_13471531 | CID_154699600 | |
| 0.223 | 0.073 | 0.256 | Interleukin antagonist | 0.168 0.105 CID_154699600 0.256 0.059 CID_13471531 | CID_13471531 | |
| 0.15 | 0.003 | 0.15 | Integrin alpha2 antagonist | 0.095 0.004 CID_154699600 0.076 0.005 CID_13471531 | ||
| 0.171 | 0.028 | 0.171 | Falcipain 3 inhibitor | 0.114 0.058 CID_154699600 0.14 0.042 CID_13471531 | ||
| 0.187 | 0.044 | 0.187 | Thiol protease inhibitor | 0.138 0.083 CID_154699600 0.151 0.068 CID_13471531 | ||
| 0.145 | 0.005 | 0.145 | Kainate receptor antagonist | 0.062 0.015 CID_154699600 0.086 0.009 CID_13471531 | ||
| 0.235 | 0.103 | 0.252 | Immunostimulant | 0.223 0.108 CID_154699600 0.252 0.095 CID_13471531 | CID_13471531 | |
| 0.137 | 0.008 | 0.167 | NMDA 2A receptor antagonist | 0.092 0.015 CID_154699600 0.167 0.006 CID_13471531 | CID_13471531 | |
| 0.146 | 0.019 | 0.146 | Interleukin 1 beta converting enzyme inhibitor | 0.125 0.031 CID_154699600 0.134 0.025 CID_13471531 | ||
| 0.21 | 0.089 | 0.242 | Angiogenesis stimulant | 0.198 0.096 CID_154699600 0.242 0.074 CID_13471531 | CID_13471531 | |
| 0.125 | 0.004 | 0.125 | AMPA 1 receptor antagonist | 0.047 0.012 CID_154699600 0.089 0.006 CID_13471531 | ||
| 0.126 | 0.005 | 0.126 | Phospholipase D inhibitor | 0.083 0.03 CID_154699600 0.095 0.018 CID_13471531 | ||
| 0.159 | 0.041 | 0.162 | Proteasome inhibitor | 0.162 0.04 CID_154699600 0.154 0.044 CID_13471531 | CID_154699600 | |
| 0.156 | 0.042 | 0.156 | Cathepsin H inhibitor | 0.112 0.086 CID_154699600 0.114 0.084 CID_13471531 | ||
| 0.121 | 0.008 | 0.121 | NMDA receptor glycine site agonist | 0.082 0.027 CID_154699600 0.091 0.022 CID_13471531 | ||
| 0.284 | 0.171 | 0.321 | Calcium channel L-type activator | 0.231 0.228 CID_154699600 0.321 0.14 CID_13471531 | CID_13471531 | |
| 0.214 | 0.103 | 0.243 | Superoxide dismutase inhibitor | 0.194 0.124 CID_154699600 0.243 0.079 CID_13471531 | CID_13471531 | |
| 0.163 | 0.054 | 0.163 | Hemostatic | 0.118 0.117 CID_154699600 0.163 0.054 CID_13471531 | ||
| 0.142 | 0.036 | 0.142 | Photosensitizer | 0.109 0.073 CID_154699600 0.133 0.043 CID_13471531 | ||
| 0.109 | 0.004 | 0.109 | Integrin beta7 antagonist | 0.098 0.004 CID_154699600 0.097 0.004 CID_13471531 | ||
| 0.108 | 0.005 | 0.108 | AMPA 4 receptor antagonist | 0.05 0.015 CID_154699600 0.066 0.009 CID_13471531 | ||
| 0.106 | 0.003 | 0.106 | Integrin alpha2beta1 antagonist | 0.058 0.004 CID_154699600 0.047 0.005 CID_13471531 | ||
| 0.282 | 0.179 | 0.288 | Cyclophilin D inhibitor | 0.279 0.182 CID_154699600 0.288 0.174 CID_13471531 | CID_13471531 | |
| 0.131 | 0.03 | 0.131 | Catalase inhibitor | 0.068 0.056 CID_154699600 0.076 0.05 CID_13471531 | ||
| 0.131 | 0.034 | 0.178 | DOPA decarboxylase inhibitor | 0.142 0.026 CID_154699600 0.178 0.011 CID_13471531 | CID_13471531 | |
| 0.101 | 0.005 | 0.101 | Kainate receptor 2 antagonist | 0.042 0.02 CID_154699600 0.052 0.015 CID_13471531 | ||
| 0.108 | 0.012 | 0.108 | Peroxisome proliferator-activated receptor gamma antagonist | 0.091 0.021 CID_154699600 0.099 0.016 CID_13471531 | ||
| 0.103 | 0.01 | 0.103 | Erythropoietin receptor agonist | 0.094 0.011 CID_154699600 0.097 0.01 CID_13471531 | ||
| 0.107 | 0.018 | 0.107 | Glucagon-like peptide 1 agonist | 0.098 0.023 CID_154699600 0.104 0.02 CID_13471531 | ||
| 0.096 | 0.008 | 0.096 | MDM2 inhibitor | 0.073 0.031 CID_154699600 0.071 0.036 CID_13471531 | ||
| 0.132 | 0.045 | 0.138 | Caspase 3 inhibitor | 0.138 0.038 CID_154699600 0.119 0.061 CID_13471531 | CID_154699600 | |
| 0.165 | 0.078 | 0.17 | ATPase inhibitor | 0.17 0.071 CID_154699600 0.162 0.082 CID_13471531 | CID_154699600 | |
| 0.135 | 0.048 | 0.218 | Cystathionine beta-synthase inhibitor | 0.176 0.031 CID_154699600 0.218 0.02 CID_13471531 | CID_13471531 | |
| 0.097 | 0.011 | 0.145 | NMDA receptor subunit 3B antagonist | 0.145 0.007 CID_154699600 0.14 0.007 CID_13471531 | CID_154699600 | |
| 0.099 | 0.014 | 0.099 | Endothelin-converting enzyme inhibitor | 0.064 0.023 CID_154699600 0.069 0.021 CID_13471531 | ||
| 0.089 | 0.005 | 0.089 | Thymidylate synthase inhibitor | 0.076 0.009 CID_154699600 0.078 0.008 CID_13471531 | ||
| 0.095 | 0.013 | 0.095 | AMPA receptor antagonist | 0.049 0.032 CID_154699600 0.062 0.024 CID_13471531 | ||
| 0.085 | 0.004 | 0.085 | AMPA 3 receptor antagonist | 0.042 0.013 CID_154699600 0.053 0.008 CID_13471531 | ||
| 0.162 | 0.081 | 0.164 | Death-associated protein kinase 2 inhibitor | 0.164 0.078 CID_13471531 | CID_13471531 | |
| 0.086 | 0.006 | 0.088 | RNA-directed RNA polymerase inhibitor | 0.078 0.007 CID_154699600 0.088 0.006 CID_13471531 | CID_13471531 | |
| 0.135 | 0.056 | 0.146 | Adenylate cyclase inhibitor | 0.103 0.082 CID_154699600 0.146 0.048 CID_13471531 | CID_13471531 | |
| 0.081 | 0.003 | 0.081 | Tryptophan 5 hydroxylase inhibitor | 0.057 0.004 CID_154699600 0.056 0.004 CID_13471531 | ||
| 0.083 | 0.005 | 0.083 | VCAM antagonist | 0.069 0.005 CID_154699600 0.068 0.005 CID_13471531 | ||
| 0.103 | 0.024 | 0.142 | Phenylalanine 4-hydroxylase inhibitor | 0.142 0.013 CID_154699600 0.113 0.02 CID_13471531 | CID_154699600 | |
| 0.082 | 0.005 | 0.082 | VCAM-1 antagonist | 0.069 0.005 CID_154699600 0.068 0.005 CID_13471531 | ||
| 0.153 | 0.076 | 0.327 | Peroxidase inhibitor | 0.13 0.091 CID_154699600 0.327 0.032 CID_13471531 | CID_13471531 | |
| 0.128 | 0.052 | 0.133 | Interleukin 8 antagonist | 0.133 0.047 CID_13471531 | CID_13471531 | |
| 0.105 | 0.03 | 0.191 | Histidine decarboxylase inhibitor | 0.135 0.022 CID_154699600 0.191 0.014 CID_13471531 | CID_13471531 | |
| 0.084 | 0.01 | 0.108 | NMDA receptor subunit 3A antagonist | 0.108 0.008 CID_154699600 0.108 0.008 CID_13471531 | CID_13471531 | |
| 0.14 | 0.067 | 0.157 | Bone formation stimulant | 0.132 0.074 CID_154699600 0.157 0.054 CID_13471531 | CID_13471531 | |
| 0.142 | 0.069 | 0.157 | Heat shock protein 70 antagonist | 0.157 0.033 CID_154699600 0.148 0.05 CID_13471531 | CID_154699600 | |
| 0.135 | 0.062 | 0.165 | Cyclooxygenase 3 inhibitor | 0.136 0.061 CID_154699600 0.165 0.037 CID_13471531 | CID_13471531 | |
| 0.105 | 0.033 | 0.105 | Inducible nitric-oxide synthase inhibitor | 0.088 0.051 CID_13471531 | ||
| 0.082 | 0.01 | 0.099 | Cathepsin L2 inhibitor | 0.099 0.008 CID_154699600 0.075 0.012 CID_13471531 | CID_154699600 | |
| 0.123 | 0.051 | 0.125 | Aminopeptidase B inhibitor | 0.125 0.05 CID_154699600 0.096 0.068 CID_13471531 | CID_154699600 | |
| 0.122 | 0.05 | 0.127 | Nav1.4 sodium channel blocker | 0.112 0.06 CID_154699600 0.127 0.047 CID_13471531 | CID_13471531 | |
| 0.117 | 0.046 | 0.117 | Falcipain inhibitor | 0.087 0.066 CID_154699600 0.112 0.048 CID_13471531 | ||
| 0.102 | 0.034 | 0.102 | Hematopoietic | 0.092 0.046 CID_154699600 0.096 0.04 CID_13471531 | ||
| 0.113 | 0.045 | 0.113 | Falcipain 2 inhibitor | 0.084 0.066 CID_154699600 0.109 0.047 CID_13471531 | ||
| 0.161 | 0.094 | 0.178 | Platelet adhesion inhibitor | 0.154 0.102 CID_154699600 0.178 0.083 CID_13471531 | CID_13471531 | |
| 0.135 | 0.068 | 0.135 | Nav1.2 sodium channel blocker | |||
| 0.072 | 0.007 | 0.072 | Prostacyclin antagonist | 0.063 0.009 CID_154699600 0.063 0.009 CID_13471531 | ||
| 0.15 | 0.087 | 0.154 | Growth hormone agonist | 0.139 0.097 CID_154699600 0.154 0.084 CID_13471531 | CID_13471531 | |
| 0.067 | 0.005 | 0.067 | Kainate receptor agonist | 0.06 0.007 CID_154699600 0.056 0.009 CID_13471531 | ||
| 0.128 | 0.067 | 0.128 | Glutamate receptor antagonist | 0.121 0.073 CID_13471531 | ||
| 0.073 | 0.012 | 0.073 | Nicotinic acid receptor 1 agonist | 0.047 0.022 CID_154699600 0.058 0.017 CID_13471531 | ||
| 0.095 | 0.035 | 0.141 | NMDA 2 receptor antagonist | 0.112 0.026 CID_154699600 0.141 0.018 CID_13471531 | CID_13471531 | |
| 0.069 | 0.01 | 0.069 | Factor XIa inhibitor | 0.041 0.027 CID_154699600 0.05 0.018 CID_13471531 | ||
| 0.072 | 0.014 | 0.072 | Cholecystokinin antagonist | 0.037 0.031 CID_154699600 0.047 0.026 CID_13471531 | ||
| 0.065 | 0.008 | 0.079 | HCV NS5B polymerase inhibitor | 0.07 0.007 CID_154699600 0.079 0.006 CID_13471531 | CID_13471531 | |
| 0.07 | 0.014 | 0.07 | Cholecystokinin A antagonist | 0.035 0.028 CID_154699600 0.039 0.025 CID_13471531 | ||
| 0.097 | 0.041 | 0.097 | Factor XII inhibitor | 0.084 0.058 CID_154699600 0.092 0.047 CID_13471531 | ||
| 0.065 | 0.01 | 0.065 | Integrin alpha5beta1 antagonist | 0.055 0.014 CID_154699600 0.056 0.014 CID_13471531 | ||
| 0.093 | 0.039 | 0.093 | Glycine receptor antagonist | |||
| 0.08 | 0.025 | 0.097 | NMDA 2C receptor antagonist | 0.097 0.017 CID_154699600 0.089 0.02 CID_13471531 | CID_154699600 | |
| 0.078 | 0.024 | 0.078 | Caspase 9 inhibitor | 0.068 0.034 CID_154699600 0.07 0.032 CID_13471531 | ||
| 0.094 | 0.041 | 0.094 | Chymotrypsin inhibitor | 0.082 0.052 CID_154699600 0.086 0.047 CID_13471531 | ||
| 0.057 | 0.005 | 0.057 | Integrin alpha1beta1 antagonist | 0.051 0.007 CID_154699600 0.05 0.007 CID_13471531 | ||
| 0.163 | 0.113 | 0.163 | Platelet aggregation inhibitor | 0.161 0.116 CID_13471531 | ||
| 0.138 | 0.088 | 0.138 | Insulin secretagoues | 0.133 0.094 CID_13471531 | ||
| 0.083 | 0.034 | 0.083 | Sphingosine 1-phosphate receptor 4 agonist | 0.062 0.052 CID_13471531 | ||
| 0.101 | 0.054 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | 0.087 0.078 CID_13471531 | ||
| 0.066 | 0.019 | 0.066 | Complement C3a chemotactic receptor antagonist | 0.053 0.025 CID_154699600 0.056 0.024 CID_13471531 | ||
| 0.068 | 0.02 | 0.068 | Bombesin 2 receptor antagonist | 0.047 0.039 CID_154699600 0.059 0.025 CID_13471531 | ||
| 0.068 | 0.021 | 0.068 | Diacylglycerol O-acyltransferase inhibitor | 0.045 0.044 CID_154699600 | ||
| 0.089 | 0.043 | 0.095 | Somatostatin 1 agonist | 0.078 0.053 CID_154699600 0.095 0.038 CID_13471531 | CID_13471531 | |
| 0.205 | 0.16 | 0.24 | Cholesterol antagonist | 0.197 0.168 CID_154699600 0.24 0.132 CID_13471531 | CID_13471531 | |
| 0.05 | 0.005 | 0.05 | LFA antagonist | 0.03 0.016 CID_154699600 0.029 0.017 CID_13471531 | ||
| 0.121 | 0.076 | 0.172 | Toll-Like receptor 2 antagonist | 0.117 0.081 CID_154699600 0.172 0.038 CID_13471531 | CID_13471531 | |
| 0.082 | 0.037 | 0.087 | GABA B receptor agonist | 0.087 0.03 CID_13471531 | CID_13471531 | |
| 0.058 | 0.015 | 0.058 | AICAR transformylase inhibitor | 0.049 0.023 CID_154699600 0.054 0.019 CID_13471531 | ||
| 0.202 | 0.161 | 0.202 | Immunomodulator | 0.184 0.182 CID_154699600 | ||
| 0.051 | 0.011 | 0.051 | AMPA 2 receptor antagonist | 0.033 0.018 CID_154699600 0.038 0.015 CID_13471531 | ||
| 0.046 | 0.006 | 0.046 | Kainate receptor 1 antagonist | 0.021 0.015 CID_13471531 | ||
| 0.066 | 0.027 | 0.09 | Beta 2 adrenoreceptor agonist | 0.09 0.005 CID_154699600 0.075 0.012 CID_13471531 | CID_154699600 | |
| 0.097 | 0.058 | 0.127 | Potassium channel (Ca-activated) activator | 0.127 0.037 CID_154699600 0.105 0.051 CID_13471531 | CID_154699600 | |
| 0.088 | 0.05 | 0.088 | 3C-Like protease (SARS coronavirus) inhibitor | 0.078 0.074 CID_154699600 0.086 0.054 CID_13471531 | ||
| 0.069 | 0.031 | 0.09 | Androgen agonist | 0.09 0.019 CID_13471531 | CID_13471531 | |
| 0.072 | 0.034 | 0.072 | Cannabinoid CB1 receptor agonist | |||
| 0.123 | 0.087 | 0.123 | Histone deacetylase SIRT1 inhibitor | 0.114 0.098 CID_154699600 0.123 0.087 CID_13471531 | ||
| 0.098 | 0.064 | 0.098 | Nitric-oxide synthase inhibitor | |||
| 0.085 | 0.051 | 0.17 | Adrenaline agonist | 0.17 0.011 CID_154699600 0.122 0.024 CID_13471531 | CID_154699600 | |
| 0.068 | 0.034 | 0.068 | Prostaglandin EP2 antagonist | 0.052 0.049 CID_154699600 0.062 0.039 CID_13471531 | ||
| 0.039 | 0.006 | 0.07 | Thyroid hormone agonist | 0.051 0.004 CID_154699600 0.07 0.003 CID_13471531 | CID_13471531 | |
| 0.101 | 0.068 | 0.124 | Mediator release inhibitor | 0.124 0.044 CID_154699600 0.111 0.057 CID_13471531 | CID_154699600 | |
| 0.061 | 0.029 | 0.061 | Angiotensin-converting enzyme inhibitor | 0.056 0.035 CID_154699600 0.058 0.033 CID_13471531 | ||
| 0.059 | 0.027 | 0.059 | Factor IXa inhibitor | 0.054 0.032 CID_154699600 0.055 0.032 CID_13471531 | ||
| 0.1 | 0.069 | 0.1 | Factor V inhibitor | 0.092 0.089 CID_154699600 0.092 0.09 CID_13471531 | ||
| 0.186 | 0.154 | 0.191 | Transcription factor STAT3 inhibitor | 0.185 0.157 CID_154699600 0.191 0.147 CID_13471531 | CID_13471531 | |
| 0.044 | 0.012 | 0.044 | Glucagon receptor antagonist | 0.039 0.014 CID_13471531 | ||
| 0.082 | 0.051 | 0.082 | Metalloproteinase-2 inhibitor | 0.079 0.054 CID_154699600 0.075 0.059 CID_13471531 | ||
| 0.076 | 0.046 | 0.076 | Aminopeptidase I inhibitor | |||
| 0.033 | 0.004 | 0.033 | Integrin beta2 antagonist | 0.012 0.009 CID_154699600 0.012 0.009 CID_13471531 | ||
| 0.034 | 0.005 | 0.034 | ICAM 1 antagonist | 0.025 0.012 CID_154699600 0.028 0.008 CID_13471531 | ||
| 0.058 | 0.03 | 0.058 | DNA helicase inhibitor | 0.056 0.035 CID_154699600 0.053 0.041 CID_13471531 | ||
| 0.193 | 0.166 | 0.193 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.036 | 0.009 | 0.036 | NMDA receptor glycine site antagonist | 0.029 0.013 CID_13471531 | ||
| 0.032 | 0.005 | 0.032 | Integrin alphaVbeta1 antagonist | 0.026 0.008 CID_154699600 0.027 0.007 CID_13471531 | ||
| 0.03 | 0.005 | 0.03 | Progesterone receptor B antagonist | 0.025 0.007 CID_154699600 0.028 0.005 CID_13471531 | ||
| 0.13 | 0.105 | 0.13 | GABA C receptor rho-2 antagonist | |||
| 0.031 | 0.007 | 0.031 | Integrin alpha4beta1 antagonist | 0.017 0.011 CID_154699600 0.017 0.011 CID_13471531 | ||
| 0.172 | 0.149 | 0.172 | Cardiotonic | |||
| 0.087 | 0.064 | 0.087 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.065 CID_13471531 | ||
| 0.145 | 0.123 | 0.147 | Succinate dehydrogenase inhibitor | 0.146 0.12 CID_154699600 0.147 0.119 CID_13471531 | CID_13471531 | |
| 0.026 | 0.005 | 0.026 | Integrin alphaLbeta2 antagonist | 0.018 0.005 CID_154699600 0.02 0.005 CID_13471531 | ||
| 0.041 | 0.019 | 0.041 | p53 inhibitor | |||
| 0.093 | 0.072 | 0.093 | Protease inhibitor | 0.083 0.082 CID_13471531 | ||
| 0.105 | 0.084 | 0.105 | Histone deacetylase class III inhibitor | 0.104 0.085 CID_13471531 | ||
| 0.04 | 0.02 | 0.04 | Glutamate (mGluR3) antagonist | |||
| 0.046 | 0.027 | 0.068 | Beta adrenoreceptor agonist | 0.068 0.005 CID_154699600 0.055 0.011 CID_13471531 | CID_154699600 | |
| 0.036 | 0.017 | 0.036 | Cholecystokinin B antagonist | |||
| 0.067 | 0.048 | 0.071 | Cyclin B3 inhibitor | 0.06 0.057 CID_154699600 0.071 0.045 CID_13471531 | CID_13471531 | |
| 0.038 | 0.018 | 0.038 | Factor XI inhibitor | |||
| 0.023 | 0.005 | 0.023 | Tryptophan hydroxylase 1 inhibitor | 0.02 0.006 CID_154699600 0.02 0.006 CID_13471531 | ||
| 0.051 | 0.032 | 0.051 | Metalloproteinase-3 inhibitor | |||
| 0.041 | 0.024 | 0.041 | Glucagon-like peptide 1 receptor antagonist | 0.04 0.027 CID_13471531 | ||
| 0.045 | 0.028 | 0.045 | Glutamate (mGluR4) antagonist | |||
| 0.032 | 0.019 | 0.032 | Dipeptidyl peptidase I inhibitor | |||
| 0.028 | 0.015 | 0.028 | Kainate receptor 4 antagonist | |||
| 0.139 | 0.126 | 0.144 | Cyclin-dependent kinase 3 inhibitor | 0.144 0.11 CID_13471531 | CID_13471531 | |
| 0.14 | 0.127 | 0.184 | DNA methylase inhibitor | 0.184 0.09 CID_13471531 | CID_13471531 | |
| 0.021 | 0.01 | 0.021 | Follicle-stimulating hormone antagonist | 0.019 0.014 CID_13471531 | ||
| 0.037 | 0.026 | 0.037 | Carbonic anhydrase I stimulant | |||
| 0.028 | 0.018 | 0.028 | Urotensin II agonist | 0.027 0.018 CID_13471531 | ||
| 0.022 | 0.013 | 0.022 | Kainate receptor 5 antagonist | |||
| 0.068 | 0.059 | 0.068 | Metalloproteinase-9 inhibitor | 0.066 0.064 CID_154699600 | ||
| 0.083 | 0.074 | 0.083 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.018 | 0.011 | 0.018 | Angiotensin-converting enzyme 2 inhibitor | 0.016 0.014 CID_154699600 0.016 0.015 CID_13471531 | ||
| 0.042 | 0.035 | 0.042 | Dihydrofolate reductase inhibitor | |||
| 0.035 | 0.028 | 0.035 | Histone deacetylase 7 inhibitor | |||
| 0.022 | 0.015 | 0.022 | Integrin alphaVbeta3 antagonist | |||
| 0.035 | 0.029 | 0.035 | Cholecystokinin B agonist | |||
| 0.063 | 0.057 | 0.064 | Elastase 1 inhibitor | 0.064 0.055 CID_13471531 | CID_13471531 | |
| 0.087 | 0.082 | 0.106 | Urease inhibitor | 0.106 0.061 CID_13471531 | CID_13471531 | |
| 0.043 | 0.038 | 0.043 | GP IIb/IIIa receptor antagonist | |||
| 0.051 | 0.046 | 0.051 | Thromboxane synthase inhibitor | |||
| 0.02 | 0.015 | 0.02 | Neutral endopeptidase inhibitor | |||
| 0.034 | 0.03 | 0.034 | Melanocortin 1 antagonist | |||
| 0.034 | 0.03 | 0.034 | Glutamate (mGluR8) antagonist | |||
| 0.043 | 0.039 | 0.043 | Melanocortin antagonist | |||
| 0.12 | 0.117 | 0.134 | Phospholipase A2 inhibitor | 0.134 0.094 CID_13471531 | CID_13471531 | |
| 0.016 | 0.013 | 0.016 | Kainate receptor 3 antagonist | |||
| 0.042 | 0.039 | 0.042 | Farnesyltransferase inhibitor | |||
| 0.039 | 0.038 | 0.043 | Neurotensin receptor antagonist | 0.043 0.033 CID_13471531 | CID_13471531 | |
| 0.013 | 0.011 | 0.013 | Glucagon agonist | |||
| 0.056 | 0.055 | 0.056 | Neutrophil collagenase inhibitor | |||
| 0.06 | 0.059 | 0.092 | Potassium channel large-conductance Ca-activated activator | 0.092 0.028 CID_154699600 0.067 0.048 CID_13471531 | CID_154699600 | |
| 0.02 | 0.02 | 0.035 | Beta 1 adrenoreceptor agonist | 0.035 0.006 CID_154699600 0.029 0.009 CID_13471531 | CID_154699600 | |
| 0.015 | 0.014 | 0.017 | Thyroid hormone alpha agonist | 0.016 0.012 CID_154699600 0.017 0.011 CID_13471531 | CID_13471531 | |
| 0.051 | 0.055 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.06 0.038 CID_154699600 | CID_154699600 | |
| 0.042 | 0.046 | 0.048 | Plasminogen activator inhibitor antagonist | 0.048 0.035 CID_154699600 0.047 0.036 CID_13471531 | CID_154699600 | |
| 0.115 | 0.12 | 0.145 | Protein-tyrosine phosphatase inhibitor | 0.145 0.084 CID_154699600 0.136 0.094 CID_13471531 | CID_154699600 | |
| 0.037 | 0.042 | 0.052 | Glycine transporter 2 inhibitor | 0.049 0.031 CID_154699600 0.052 0.029 CID_13471531 | CID_13471531 | |
| 0.023 | 0.028 | 0.028 | Protocollagen prolyl hydroxylase inhibitor | 0.028 0.019 CID_154699600 0.025 0.023 CID_13471531 | CID_154699600 | |
| 0.044 | 0.051 | 0.047 | CD45 antagonist | 0.047 0.043 CID_13471531 | CID_13471531 | |
| 0.197 | 0.206 | 0.243 | Histamine release inhibitor | 0.243 0.16 CID_13471531 | CID_13471531 | |
| 0.071 | 0.083 | 0.098 | Opioid antagonist | 0.077 0.073 CID_154699600 0.098 0.049 CID_13471531 | CID_13471531 | |
| 0.005 | 0.018 | 0.009 | Thyroid hormone beta agonist | 0.009 0.005 CID_13471531 | CID_13471531 | |
| 0.156 | 0.169 | 0.194 | Hypoglycemic | 0.194 0.118 CID_13471531 | CID_13471531 | |
| 0.158 | 0.172 | 0.172 | Peptidyltransferase inhibitor | 0.169 0.148 CID_154699600 0.172 0.142 CID_13471531 | CID_13471531 | |
| 0.123 | 0.14 | 0.158 | DNA methyltransferase I inhibitor | 0.158 0.096 CID_13471531 | CID_13471531 | |
| 0.106 | 0.126 | 0.12 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.095 CID_154699600 0.12 0.081 CID_13471531 | CID_13471531 | |
| 0.082 | 0.104 | 0.094 | AMP-activated protein kinase stimulant | 0.094 0.079 CID_13471531 | CID_13471531 | |
| 0.036 | 0.059 | 0.062 | Beta 2 adrenoreceptor antagonist | 0.062 0.022 CID_154699600 0.051 0.035 CID_13471531 | CID_154699600 | |
| 0.066 | 0.09 | 0.097 | Antineoplastic alkaloid | 0.097 0.05 CID_154699600 0.079 0.067 CID_13471531 | CID_154699600 | |
| 0.053 | 0.08 | 0.068 | Beta 3 adrenoreceptor antagonist | 0.068 0.037 CID_154699600 0.063 0.047 CID_13471531 | CID_154699600 | |
| 0.078 | 0.105 | 0.093 | Bile acid receptor antagonist | 0.093 0.067 CID_13471531 | CID_13471531 | |
| 0.04 | 0.067 | 0.07 | Opioid delta receptor antagonist | 0.07 0.04 CID_13471531 | CID_13471531 | |
| 0.07 | 0.101 | 0.092 | Alcohol dehydrogenase inhibitor | 0.092 0.061 CID_13471531 | CID_13471531 | |
| 0.089 | 0.12 | 0.109 | Aldehyde dehydrogenase inhibitor | 0.109 0.084 CID_13471531 | CID_13471531 | |
| 0.045 | 0.076 | 0.072 | Opioid mu receptor antagonist | 0.072 0.044 CID_13471531 | CID_13471531 | |
| 0.046 | 0.079 | 0.053 | Adenine nucleotide translocase inhibitor | 0.053 0.047 CID_154699600 0.052 0.051 CID_13471531 | CID_154699600 | |
| 0.068 | 0.105 | 0.082 | Prolactin inhibitor | 0.082 0.078 CID_13471531 | CID_13471531 | |
| 0.03 | 0.068 | 0.041 | Opioid mu receptor agonist | 0.041 0.039 CID_13471531 | CID_13471531 | |
| 0.046 | 0.087 | 0.074 | Beta adrenoreceptor antagonist | 0.074 0.033 CID_154699600 0.061 0.054 CID_13471531 | CID_154699600 | |
| 0.165 | 0.208 | 0.253 | Transcription factor NF kappa B inhibitor | 0.253 0.125 CID_13471531 | CID_13471531 | |
| 0.108 | 0.157 | 0.129 | Adenylate cyclase stimulant | 0.129 0.104 CID_13471531 | CID_13471531 | |
| 0.069 | 0.12 | 0.097 | Carbonic anhydrase III inhibitor | 0.097 0.065 CID_13471531 | CID_13471531 | |
| 0.121 | 0.172 | 0.204 | Aldehyde oxidase inhibitor | 0.204 0.103 CID_13471531 | CID_13471531 | |
| 0.107 | 0.166 | 0.146 | Melanin inhibitor | 0.146 0.088 CID_13471531 | CID_13471531 | |
| 0.059 | 0.119 | 0.166 | Bronchodilator | 0.166 0.026 CID_154699600 0.09 0.074 CID_13471531 | CID_154699600 | |
| 0.071 | 0.139 | 0.127 | Amylase inhibitor | 0.127 0.076 CID_13471531 | CID_13471531 | |
| 0.12 | 0.191 | 0.217 | Free radical scavenger | 0.196 0.101 CID_154699600 0.217 0.085 CID_13471531 | CID_13471531 | |
| 0.063 | 0.144 | 0.119 | Chelator | 0.119 0.055 CID_154699600 0.094 0.087 CID_13471531 | CID_154699600 | |
| 0.175 | 0.262 | 0.243 | Antibacterial | 0.243 0.184 CID_154699600 | CID_154699600 | |
| 0.109 | 0.202 | 0.163 | Antiamyloidogenic | 0.152 0.144 CID_154699600 0.163 0.13 CID_13471531 | CID_13471531 | |
| 0.089 | 0.212 | 0.133 | Dual specificity phosphatase inhibitor | 0.133 0.116 CID_154699600 | CID_154699600 | |
| 0.098 | 0.257 | 0.19 | Antioxidant | 0.173 0.139 CID_154699600 0.19 0.122 CID_13471531 | CID_13471531 | |
| 0.06 | 0.237 | 0.156 | Amyloid beta aggregation inhibitor | 0.156 0.104 CID_154699600 | CID_154699600 | |
| 0.124 | 0.323 | 0.208 | Sodium/bile acid cotransporter inhibitor | 0.208 0.177 CID_13471531 | CID_13471531 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |